Biologics

Biologics

Signal active

Organization

Contact Information

Overview

Biologics, Inc. is an oncology management services company that empowers healthcare providers, payors and biopharma to optimize cancer care for the best possible outcomes – clinical, financial and emotional. Unifying fragmented healthcare services, Biologics brings efficiency and humanity to oncology care management by focusing on the patient’s best interest as the surest path to managing cost and risk. Biologics is at the center of a rapidly changing oncology environment and supports patients across all treatment modalities. Offering a holistic approach to oncology care, the company provides the following services: Care Integration, Oncology Pharmacy Services, Patient Access Services, Strategic Market Solutions and Clinical Research Services. Biologics was founded in 1994 and maintains headquarters and operations in Cary, North Carolina.

About

Industries

Finance, Biotechnology, Health Care, Biopharma, Oncology

Founded

1994

Employees

251-500

Headquarters locations

Cary, North Carolina, United States, North America

Social

Profile Resume

Biologics headquartered in United States, North America, operates in the Finance, Biotechnology, Health Care, Biopharma, Oncology sector. The company focuses on Finance and has secured $1.2B in funding across 40 round(s). With a team of 251-500 employees, Biologics is actively contributing to advancements in Finance. Their latest funding round, Venture Round - Biologics, raised $821.9K. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Leah M. Devlin

Leah M. Devlin

Board Of Directors

imagePlace Robin Smith

Robin Smith

Chairman & CEO

imagePlace Karen Freeman

Karen Freeman

Chief Operating Officer

Funding Rounds

Funding rounds

2

Investors

0

Lead Investors

0

Total Funding Amount

$29.8M

Details

0

Biologics has raised a total of $29.8M in funding over 0 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor

Investors

There is no investor info for this profile.